80 related articles for article (PubMed ID: 25688115)
1. Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.
Ohri N; Duan F; Machtay M; Gorelick JJ; Snyder BS; Alavi A; Siegel BA; Johnson DW; Bradley JD; DeNittis A; Werner-Wasik M
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25688115
[TBL] [Abstract][Full Text] [Related]
2. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients.
Ohno Y; Yui M; Yamamoto K; Takenaka D; Koyama H; Nagata H; Ueda T; Ikeda H; Ozawa Y; Toyama H; Yoshikawa T
J Magn Reson Imaging; 2023 Jul; 58(1):174-186. PubMed ID: 36971493
[TBL] [Abstract][Full Text] [Related]
3. Does Tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Kernstine KH; Faubert B; Do QN; Rogers TJ; Hensley CT; Cai L; Torrealba J; Oliver D; Wachsmann JW; Lenkinski RE; Malloy CR; Deberardinis RJ
Ann Thorac Surg; 2020 Apr; 109(4):1019-1025. PubMed ID: 31846640
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
[TBL] [Abstract][Full Text] [Related]
5. Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.
Zhang W; Ning N; Li X; Niu G; Bai L; Guo Y; Yang J
PLoS One; 2016; 11(8):e0161325. PubMed ID: 27529342
[TBL] [Abstract][Full Text] [Related]
6. Need for objective task-based evaluation of AI-based segmentation methods for quantitative PET.
Liu Z; Mhlanga JC; Siegel BA; Jha AK
ArXiv; 2023 Mar; ():. PubMed ID: 36911274
[TBL] [Abstract][Full Text] [Related]
7. PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.
Konert T; Vogel W; MacManus MP; Nestle U; Belderbos J; Grégoire V; Thorwarth D; Fidarova E; Paez D; Chiti A; Hanna GG
Radiother Oncol; 2015 Jul; 116(1):27-34. PubMed ID: 25869338
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of early response assessment using 18F-FDG PET/CT in chemotherapy-treated patients with non-small-cell lung cancer.
Han EJ; Yang YJ; Park JC; Park SY; Choi WH; Kim SH
Nucl Med Commun; 2015 Dec; 36(12):1187-94. PubMed ID: 26375438
[TBL] [Abstract][Full Text] [Related]
9. Metabolic response assessment with
Wang J; Wong KK; Piert M; Stanton P; Frey KA; Kong FS
J Radiat Oncol; 2015; 4(3):249-256. PubMed ID: 26366253
[TBL] [Abstract][Full Text] [Related]
10. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Eberhardt WE; De Ruysscher D; Weder W; Le Péchoux C; De Leyn P; Hoffmann H; Westeel V; Stahel R; Felip E; Peters S;
Ann Oncol; 2015 Aug; 26(8):1573-88. PubMed ID: 25897013
[TBL] [Abstract][Full Text] [Related]
11. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.
Rodrigues G; Oberije C; Senan S; Tsujino K; Wiersma T; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; DeRuyck K; De Dios NR; Warner A; Bradley JD; Palma DA
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):133-9. PubMed ID: 25835622
[TBL] [Abstract][Full Text] [Related]
12. Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?
Bertolaccini L; Terzi A; Ricchetti F; Alongi F
Ann Transl Med; 2015 Feb; 3(2):25. PubMed ID: 25738145
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome.
Lokre O; Perk TG; Weisman AJ; Govindan RM; Chen S; Chen M; Eickhoff J; Liu G; Jeraj R
Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38819668
[TBL] [Abstract][Full Text] [Related]
14. Need for Objective Task-Based Evaluation of Image Segmentation Algorithms for Quantitative PET: A Study with ACRIN 6668/RTOG 0235 Multicenter Clinical Trial Data.
Liu Z; Mhlanga JC; Xia H; Siegel BA; Jha AK
J Nucl Med; 2024 Mar; 65(3):485-92. PubMed ID: 38360049
[TBL] [Abstract][Full Text] [Related]
15. Need for objective task-based evaluation of AI-based segmentation methods for quantitative PET.
Liu Z; Mhlanga JC; Siegel BA; Jha AK
Proc SPIE Int Soc Opt Eng; 2023 Feb; 12467():. PubMed ID: 37990707
[TBL] [Abstract][Full Text] [Related]
16. No-gold-standard evaluation of quantitative imaging methods in the presence of correlated noise.
Liu Z; Li Z; Mhlanga JC; Siegel BA; Jha AK
Proc SPIE Int Soc Opt Eng; 2022; 12035():. PubMed ID: 36465994
[TBL] [Abstract][Full Text] [Related]
17. Influencing Factors and Prognostic Value of
Zhang L; Ren Z; Xu C; Li Q; Chen J
Int J Gen Med; 2021; 14():3699-3706. PubMed ID: 34321915
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian approach to tissue-fraction estimation for oncological PET segmentation.
Liu Z; Mhlanga JC; Laforest R; Derenoncourt PR; Siegel BA; Jha AK
Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34125078
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
